Thrivent Financial for Lutherans Raises Stock Holdings in Globe Life Inc. $GL

Thrivent Financial for Lutherans grew its stake in shares of Globe Life Inc. (NYSE:GL) by 156.1% during the third quarter, HoldingsChannel.com reports. The fund owned 8,310 shares of the company’s stock after buying an additional 5,065 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Globe Life were worth $1,188,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Significant Wealth Partners LLC bought a new position in Globe Life during the third quarter valued at approximately $219,000. AlphaQuest LLC purchased a new stake in Globe Life during the 3rd quarter valued at $693,000. Arizona State Retirement System raised its stake in Globe Life by 0.5% during the 3rd quarter. Arizona State Retirement System now owns 24,424 shares of the company’s stock valued at $3,492,000 after buying an additional 130 shares during the last quarter. Pittenger & Anderson Inc. bought a new position in shares of Globe Life during the 3rd quarter valued at $349,000. Finally, Impact Partnership Wealth LLC boosted its stake in shares of Globe Life by 11.2% in the 3rd quarter. Impact Partnership Wealth LLC now owns 3,149 shares of the company’s stock worth $450,000 after buying an additional 317 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on GL. Weiss Ratings upgraded Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday. Evercore downgraded Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price target for the company. in a research note on Tuesday, January 6th. Wells Fargo & Company reduced their price target on shares of Globe Life from $172.00 to $170.00 and set an “overweight” rating for the company in a research report on Friday, October 24th. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Truist Financial boosted their target price on shares of Globe Life from $158.00 to $180.00 and gave the company a “buy” rating in a research report on Friday, February 6th. Eight equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, Globe Life presently has an average rating of “Moderate Buy” and an average target price of $171.00.

Insider Activity

In related news, EVP Michael Clay Majors sold 30,000 shares of Globe Life stock in a transaction on Friday, February 6th. The shares were sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the transaction, the executive vice president owned 47,066 shares in the company, valued at approximately $6,913,524.74. The trade was a 38.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 9,379 shares of the company’s stock in a transaction on Tuesday, December 16th. The stock was sold at an average price of $140.43, for a total transaction of $1,317,092.97. Following the completion of the transaction, the chief executive officer directly owned 35,868 shares of the company’s stock, valued at $5,036,943.24. This represents a 20.73% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 51,129 shares of company stock valued at $7,414,035. 1.51% of the stock is currently owned by company insiders.

Globe Life Stock Up 0.2%

NYSE GL opened at $144.46 on Friday. Globe Life Inc. has a 52 week low of $109.38 and a 52 week high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $11.50 billion, a P/E ratio of 10.26 and a beta of 0.47. The stock’s 50-day moving average price is $140.57 and its 200-day moving average price is $138.41.

Globe Life (NYSE:GL) last released its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a return on equity of 21.75% and a net margin of 19.37%.The firm had revenue of $1.52 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the prior year, the company posted $3.14 earnings per share. The company’s revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. On average, equities research analysts predict that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.